your badges 52W Range $3–$142 0% of range Analyst Rating · Price Target · P/E · ROE · Net Profit Margin ·

LIMN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $2.94
Market Cap (MRQ) $132M
Debt/Equity (MRQ) -10.9
52W Range $3–$142

LIMN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

Stock splits 1
Ex-date Split Type
Aug. 21, 2026 1-for-50 Reverse

10-Year Performance Revenue, net income, margins and EPS trends

06
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend LIMN 5Y avg Peer Median Verdict
P/B (MRQ) -995.1 · · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Next Report Nov 12, 2026

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
No annual filings for LIMN

We don't have SEC filings for this ticker yet.

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
No data for this statement

Not enough fundamentals data to build this statement yet.

Institutional owners (13F) 15 filers · $114K total · As of June 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 15
Value held $114K
New positions 4
Exited positions 5
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
4 (-2 vs prior Q) 5 (+3 vs prior Q) 1 (-4 vs prior Q) 6 (+3 vs prior Q) -529K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
VANGUARD GROUP INC $44,788 73,424 39.31% Shares
XTX Topco Ltd $24,491 221,839 21.50% Shares
GEODE CAPITAL MANAGEMENT, LLC $15,282 138,418 13.41% Shares
CITADEL ADVISORS LLC $6,192 56,089 5.44% Shares
VANGUARD CAPITAL MANAGEMENT LLC $5,548 50,440 4.87% Shares
GOLDMAN SACHS GROUP INC $4,440 40,220 3.90% Shares
StoneX Group Inc. $3,934 26,058 3.45% Shares
VANGUARD FIDUCIARY TRUST CO $2,528 22,984 2.22% Shares
STATE STREET CORP $2,098 19,000 1.84% Shares
UBS Group AG $1,840 16,730 1.62% Shares
Vanguard Personalized Indexing Management, LLC $1,452 13,148 1.27% Shares
Tower Research Capital LLC (TRC) $783 7,093 0.69% Shares
BARCLAYS PLC $474 4,290 0.42% Shares
Cygnus Capital Advisors, LLC $36 329,333 0.03% Shares
BlackRock, Inc. $35 313 0.03% Shares

Activists & 5%+ owners 2 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Iris Acquisition Holdings LLC May 8, 2025 26.50% Initial filing Passive investment SEC
Valetudo Therapeutics LLC, Chris Kim May 7, 2025 23.70% Initial filing Passive investment SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF ownership Held by 1 ETF

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
VXF · VANGUARD INDEX FUNDS 0.00% 50,440 SH Aug. 19, 2026 Daily

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
LIMN · · · · · ·
XBIO · -1.4 19.0% · · ·
DRMA · · · · · ·
PMCB $8M -0.3 · · -56.7% ·
BIAF · · · · · ·
KALA $15M -0.2 · · -1423.8% ·

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed May 15, 2026